|
Novel |
RAB14 |
RAB14, member RAS oncogene family |
- Translocation of SLC2A4 (GLUT4) to the plasma membrane
- Synthesis of PIPs at the plasma membrane
- Neutrophil degranulation
- RAB geranylgeranylation
- RAB GEFs exchange GTP for GDP on RABs
|
|
|
|
|
BCL10 |
BCL10 immune signaling adaptor |
- Activation of NF-kappaB in B cells
- Activation of NF-kappaB in B cells
- Downstream TCR signaling
- FCERI mediated NF-kB activation
- FCERI mediated NF-kB activation
- CLEC7A (Dectin-1) signaling
- E3 ubiquitin ligases ubiquitinate target proteins
|
|
|
|
|
BTK |
Bruton tyrosine kinase |
- ER-Phagosome pathway
- MyD88:MAL(TIRAP) cascade initiated on plasma membrane
- Regulation of actin dynamics for phagocytic cup formation
- DAP12 signaling
- FCERI mediated Ca+2 mobilization
- FCERI mediated Ca+2 mobilization
- G alpha (q) signalling events
- G alpha (12/13) signalling events
- MyD88 deficiency (TLR2/4)
- IRAK4 deficiency (TLR2/4)
- RHO GTPases Activate WASPs and WAVEs
- G beta:gamma signalling through BTK
- FCGR3A-mediated phagocytosis
- Potential therapeutics for SARS
- Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
- Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
|
- Dasatinib
- Inositol 1,3,4,5-Tetrakisphosphate
- XL418
- Ibrutinib
- Acalabrutinib
- Spebrutinib
- Fostamatinib
- Fenebrutinib
- Zanubrutinib
- Evobrutinib
- Tirabrutinib
- Abivertinib
- Branebrutinib
- Vecabrutinib
|
- Pituitary Dwarfism (PD); Isolated growth hormone deficiency (IGHD); Short Stature and Pituitary Defects (SSPD); Insulin-like growth factor 1 deficiency (IGFD)
- Agammaglobulinemias, including the following six diseases: X-linked agammaglobulinemia (Bruton's agammaglobulinemia, XLA); IgM heavy chain gene deletions; Ig-alpha defect; Autosomal recessive agammaglobulinaemia; B cell-linker protein (BLNK) deficiency; Leucine-rich repeat-containing 8
|
|
|
CD14 |
CD14 molecule |
- ER-Phagosome pathway
- Caspase activation via Death Receptors in the presence of ligand
- Toll Like Receptor 4 (TLR4) Cascade
- Transfer of LPS from LBP carrier to CD14
- MyD88:MAL(TIRAP) cascade initiated on plasma membrane
- MyD88-independent TLR4 cascade
- Toll Like Receptor TLR1:TLR2 Cascade
- Toll Like Receptor TLR6:TLR2 Cascade
- TRIF-mediated programmed cell death
- MyD88 deficiency (TLR2/4)
- IRAK4 deficiency (TLR2/4)
- Regulation of TLR by endogenous ligand
- Neutrophil degranulation
- Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE)
- IKK complex recruitment mediated by RIP1
- TRAF6-mediated induction of TAK1 complex within TLR4 complex
- IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation
- Respiratory syncytial virus (RSV) attachment and entry
- Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7
- RSV-host interactions
|
|
|
|
|
CNPY4 |
canopy FGF signaling regulator 4 |
|
|
|
|
|
DEFB4A |
defensin beta 4A |
|
|
|
|
|
FN1 |
fibronectin 1 |
- Platelet degranulation
- Degradation of the extracellular matrix
- Degradation of the extracellular matrix
- Fibronectin matrix formation
- Cell surface interactions at the vascular wall
- Molecules associated with elastic fibres
- Integrin cell surface interactions
- Syndecan interactions
- Non-integrin membrane-ECM interactions
- ECM proteoglycans
- Integrin signaling
- GRB2:SOS provides linkage to MAPK signaling for Integrins
- p130Cas linkage to MAPK signaling for integrins
- Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
- MAP2K and MAPK activation
- Interleukin-4 and Interleukin-13 signaling
- Signaling by moderate kinase activity BRAF mutants
- Signaling by high-kinase activity BRAF mutants
- Signaling by BRAF and RAF1 fusions
- Paradoxical activation of RAF signaling by kinase inactive BRAF
- MET activates PTK2 signaling
- Post-translational protein phosphorylation
- GPER1 signaling
- Attachment of bacteria to epithelial cells
- Signaling downstream of RAS mutants
- Signaling by RAF1 mutants
- ALK mutants bind TKIs
- Signaling by ALK fusions and activated point mutants
- Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells
- Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells
- Developmental Lineage of Pancreatic Ductal Cells
|
- Zinc
- Lanoteplase
- Ocriplasmin
- Zinc acetate
- Zinc chloride
- Zinc sulfate, unspecified form
|
|
|
|
HMGB1 |
high mobility group box 1 |
- ER-Phagosome pathway
- Apoptosis induced DNA fragmentation
- MyD88:MAL(TIRAP) cascade initiated on plasma membrane
- TAK1-dependent IKK and NF-kappa-B activation
- MyD88 deficiency (TLR2/4)
- IRAK4 deficiency (TLR2/4)
- Pyroptosis
- Regulation of TLR by endogenous ligand
- Neutrophil degranulation
- Advanced glycosylation endproduct receptor signaling
- Advanced glycosylation endproduct receptor signaling
- TRAF6 mediated NF-kB activation
|
- Chloroquine
- Ethyl pyruvate
|
|
|
|
HSP90B1 |
heat shock protein 90 beta family member 1 |
- Trafficking and processing of endosomal TLR
- Scavenging by Class A Receptors
- Scavenging by Class A Receptors
- ATF6 (ATF6-alpha) activates chaperone genes
- Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
- Interleukin-4 and Interleukin-13 signaling
- Post-translational protein phosphorylation
|
- Rifabutin
- 2-Chlorodideoxyadenosine
- Geldanamycin
- Diglyme
- N-Ethyl-5'-Carboxamido Adenosine
- Radicicol
- METHYL 3-CHLORO-2-{3-[(2,5-DIHYDROXY-4-METHOXYPHENYL)AMINO]-3-OXOPROPYL}-4,6-DIHYDROXYBENZOATE
- 2-(3-AMINO-2,5,6-TRIMETHOXYPHENYL)ETHYL 5-CHLORO-2,4-DIHYDROXYBENZOATE
- Copper
|
|
|
|
IRAK1 |
interleukin 1 receptor associated kinase 1 |
- PIP3 activates AKT signaling
- MyD88:MAL(TIRAP) cascade initiated on plasma membrane
- NOD1/2 Signaling Pathway
- p75NTR recruits signalling complexes
- p75NTR recruits signalling complexes
- NF-kB is activated and signals survival
- TAK1-dependent IKK and NF-kappa-B activation
- activated TAK1 mediates p38 MAPK activation
- JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1
- PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
- Transcriptional Regulation by MECP2
- Interleukin-1 signaling
- IRAK1 recruits IKK complex
- SARS-CoV-2 activates/modulates innate and adaptive immune responses
- TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling
- TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
- IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation
- MyD88 dependent cascade initiated on endosome
- MyD88 cascade initiated on plasma membrane
|
|
|
|
|
IRAK2 |
interleukin 1 receptor associated kinase 2 |
- MyD88:MAL(TIRAP) cascade initiated on plasma membrane
- NOD1/2 Signaling Pathway
- TAK1-dependent IKK and NF-kappa-B activation
- activated TAK1 mediates p38 MAPK activation
- JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1
- Interleukin-1 signaling
- IRAK2 mediated activation of TAK1 complex
- TRAF6-mediated induction of TAK1 complex within TLR4 complex
- SARS-CoV-1 activates/modulates innate immune responses
- SARS-CoV-2 activates/modulates innate and adaptive immune responses
- TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
- MyD88 dependent cascade initiated on endosome
- IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation
- MyD88 cascade initiated on plasma membrane
|
|
|
|
|
LY96 |
lymphocyte antigen 96 |
- ER-Phagosome pathway
- Caspase activation via Death Receptors in the presence of ligand
- Toll Like Receptor 4 (TLR4) Cascade
- MyD88:MAL(TIRAP) cascade initiated on plasma membrane
- MyD88-independent TLR4 cascade
- TRIF-mediated programmed cell death
- MyD88 deficiency (TLR2/4)
- IRAK4 deficiency (TLR2/4)
- Regulation of TLR by endogenous ligand
- Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE)
- IKK complex recruitment mediated by RIP1
- TRAF6-mediated induction of TAK1 complex within TLR4 complex
- Heme signaling
- IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation
- Respiratory syncytial virus (RSV) attachment and entry
- Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7
- RSV-host interactions
|
- Morphine
- (R)-3-hydroxytetradecanoic acid
- Lauric acid
- Myristic acid
|
|
|
|
MAPK8IP3 |
mitogen-activated protein kinase 8 interacting protein 3 |
|
|
|
|
|
MYD88 |
MYD88 innate immune signal transduction adaptor |
- ER-Phagosome pathway
- PIP3 activates AKT signaling
- MyD88:MAL(TIRAP) cascade initiated on plasma membrane
- RIP-mediated NFkB activation via ZBP1
- p75NTR recruits signalling complexes
- p75NTR recruits signalling complexes
- DEx/H-box helicases activate type I IFN and inflammatory cytokines production
- MyD88 deficiency (TLR2/4)
- MyD88 deficiency (TLR5)
- IRAK4 deficiency (TLR5)
- IRAK4 deficiency (TLR2/4)
- PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
- Interleukin-1 signaling
- TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling
- TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
- MyD88 dependent cascade initiated on endosome
- MyD88 cascade initiated on plasma membrane
|
|
|
|
|
NOX4 |
NADPH oxidase 4 |
- Detoxification of Reactive Oxygen Species
- STAT5 activation downstream of FLT3 ITD mutants
- Signaling by FLT3 fusion proteins
|
|
|
|
|
RIPK2 |
receptor interacting serine/threonine kinase 2 |
- NOD1/2 Signaling Pathway
- NOD1/2 Signaling Pathway
- Downstream TCR signaling
- p75NTR recruits signalling complexes
- TAK1-dependent IKK and NF-kappa-B activation
- activated TAK1 mediates p38 MAPK activation
- JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1
- Ovarian tumor domain proteases
- Interleukin-1 signaling
- SARS-CoV-2 activates/modulates innate and adaptive immune responses
|
|
|
|
|
RNF216 |
ring finger protein 216 |
- Negative regulators of DDX58/IFIH1 signaling
|
|
|
|
|
SERTAD1 |
SERTA domain containing 1 |
|
|
|
|
|
SIGIRR |
single Ig and TIR domain containing |
- MyD88:MAL(TIRAP) cascade initiated on plasma membrane
- Interleukin-37 signaling
|
|
|
|
|
SMAD3 |
SMAD family member 3 |
- Signaling by NODAL
- Signaling by NODAL
- Signaling by Activin
- Signaling by Activin
- Downregulation of TGF-beta receptor signaling
- TGF-beta receptor signaling activates SMADs
- Downregulation of SMAD2/3:SMAD4 transcriptional activity
- Downregulation of SMAD2/3:SMAD4 transcriptional activity
- SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
- SMAD2/3 Phosphorylation Motif Mutants in Cancer
- SMAD4 MH2 Domain Mutants in Cancer
- SMAD2/3 MH2 Domain Mutants in Cancer
- TGFBR1 KD Mutants in Cancer
- Ub-specific processing proteases
- RUNX3 regulates CDKN1A transcription
- RUNX3 regulates BCL2L11 (BIM) transcription
- Interleukin-37 signaling
- NOTCH4 Intracellular Domain Regulates Transcription
- FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
- FOXO-mediated transcription of cell cycle genes
- FOXO-mediated transcription of cell cycle genes
- SARS-CoV-1 targets host intracellular signalling and regulatory pathways
- Germ layer formation at gastrulation
- Formation of axial mesoderm
- Formation of definitive endoderm
- Formation of definitive endoderm
- TGFBR3 expression
|
|
|